Developing Growth Fund
Daily price w/o sales charge as of 06/02/2023
$18.65
$0.30
YTD Returns w/o sales charge as of 06/02/2023
10.03%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 04/28/2023
- Total Net Assets
- $2.60 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 0.94%
- Fund Net Expense Ratio
- 0.94%
- Number of Holdings
- 91
- Minimum Initial Investment
- $1,000+
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 7.37% | 1.00% | 1.63% | 5.76% | 9.43% | 10.35% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell 2000® Growth Index | 4.86% | 2.68% | 4.62% | 2.74% | 7.90% | - |
| w/ sales charge | 1.22% | -4.81% | -0.36% | 4.51% | 8.79% | 10.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 8.32% | -14.25% | 11.86% | 8.51% | 10.26% | 10.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.15% | -11.42% | 15.85% | 6.85% | 9.32% | - |
| Russell 2000® Growth Index | 6.07% | -10.60% | 13.36% | 4.26% | 8.49% | - |
| w/ sales charge | 2.11% | -19.19% | 9.67% | 7.24% | 9.60% | 10.28% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 04/28/2023View Portfolio
| Holding | Assets |
|---|---|
| Apellis Pharmaceuticals Inc | 2.4% |
| TransMedics Group Inc | 2.3% |
| Duolingo Inc | 2.2% |
| Crocs Inc | 2.1% |
| Inspire Medical Systems Inc | 2.1% |
| Deckers Outdoor Corp | 1.9% |
| Ventyx Biosciences Inc | 1.9% |
| Wingstop Inc | 1.9% |
| Xenon Pharmaceuticals Inc | 1.9% |
| Lattice Semiconductor Corp | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 04/28/2023View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Other | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 7.37% | 1.00% | 1.63% | 5.76% | 9.43% | 10.35% |
| Lipper Category Avg. Small-Cap Growth Funds | - | - | - | - | - | - |
| Russell 2000® Growth Index | 4.86% | 2.68% | 4.62% | 2.74% | 7.90% | - |
| w/ sales charge | 1.22% | -4.81% | -0.36% | 4.51% | 8.79% | 10.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | 8.32% | -14.25% | 11.86% | 8.51% | 10.26% | 10.41% |
| Lipper Category Avg. Small-Cap Growth Funds | 6.15% | -11.42% | 15.85% | 6.85% | 9.32% | - |
| Russell 2000® Growth Index | 6.07% | -10.60% | 13.36% | 4.26% | 8.49% | - |
| w/ sales charge | 2.11% | -19.19% | 9.67% | 7.24% | 9.60% | 10.28% |
Fund Expense Ratio :
Gross 0.94%
Net 0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2022 | -36.09% | -26.36% |
| 2021 | -2.66% | 2.83% |
| 2020 | 72.57% | 34.63% |
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | 5.60% |
| 2013 | 57.19% | 43.30% |
| 2012 | 10.39% | - |
| 2011 | -1.66% | - |
| 2010 | 36.54% | - |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| 2004 | 6.00% | - |
| 2003 | 40.06% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2023 | 8.32% | - | - | - | 10.03% |
| 2022 | -19.27% | -21.16% | 0.59% | -0.18% | -36.09% |
| 2021 | 1.64% | 2.87% | -3.66% | -3.35% | -2.66% |
| 2020 | -16.91% | 40.59% | 15.92% | 27.45% | 72.57% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% | 31.91% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% | 5.09% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% | 29.92% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% | -2.71% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% | -8.90% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% | 3.25% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% | 57.19% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% | 10.39% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% | -1.66% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% | 36.54% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% | 47.03% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% | -47.50% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% | 35.83% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% | 12.45% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% | 11.87% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% | 6.00% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% | 40.06% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% | -29.54% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% | -6.98% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% | -17.69% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% | 38.16% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% | 8.27% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% | 30.78% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% | 22.19% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% | 45.66% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% | 6.20% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% | 12.62% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% | -3.06% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% | 56.36% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% | -6.41% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% | 14.12% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% | 3.45% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% | 0.76% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% | 0.42% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% | 14.96% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% | -22.39% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% | 24.68% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% | 29.58% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% | 7.74% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% | 35.80% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% | 28.29% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% | 35.51% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% | 13.12% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% | 19.57% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% | 38.93% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% | -35.69% |
| 1973 | - | - | - | - | -9.00% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 03/31/2023
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Apellis Pharmaceuticals Inc | Health Care | 2.4% |
| TransMedics Group Inc | Health Care | 2.3% |
| Duolingo Inc | Consumer Discretionary | 2.2% |
| Crocs Inc | Consumer Discretionary | 2.1% |
| Inspire Medical Systems Inc | Health Care | 2.1% |
| Deckers Outdoor Corp | Consumer Discretionary | 1.9% |
| Ventyx Biosciences Inc | Health Care | 1.9% |
| Wingstop Inc | Consumer Discretionary | 1.9% |
| Xenon Pharmaceuticals Inc | Health Care | 1.9% |
| Lattice Semiconductor Corp | Information Technology | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Apellis Pharmaceuticals Inc | Health Care | 2.4% |
| TransMedics Group Inc | Health Care | 2.3% |
| Duolingo Inc | Consumer Discretionary | 2.2% |
| Inspire Medical Systems Inc | Health Care | 2.1% |
| Crocs Inc | Consumer Discretionary | 2.1% |
| Xenon Pharmaceuticals Inc | Health Care | 1.9% |
| Deckers Outdoor Corp | Consumer Discretionary | 1.9% |
| Wingstop Inc | Consumer Discretionary | 1.9% |
| Ventyx Biosciences Inc | Health Care | 1.9% |
| Lattice Semiconductor Corp | Information Technology | 1.8% |
| Clear Secure Inc | Information Technology | 1.8% |
| Flywire Corp | Financials | 1.8% |
| Diodes Inc | Information Technology | 1.7% |
| Axon Enterprise, Inc. | Industrials | 1.7% |
| Remitly Global Inc | Financials | 1.6% |
| Rambus Inc | Information Technology | 1.6% |
| Shift4 Payments Inc | Financials | 1.6% |
| DoubleVerify Holdings Inc | Information Technology | 1.6% |
| Planet Fitness Inc | Consumer Discretionary | 1.6% |
| Lantheus Holdings Inc | Health Care | 1.5% |
| Wynn Resorts Ltd | Consumer Discretionary | 1.5% |
| Krystal Biotech Inc | Health Care | 1.5% |
| Dick's Sporting Goods Inc | Consumer Discretionary | 1.5% |
| Shockwave Medical Inc | Health Care | 1.5% |
| 10X Genomics Inc | Health Care | 1.4% |
| Impinj Inc | Information Technology | 1.4% |
| Global-e Online Ltd | Consumer Discretionary | 1.4% |
| Cytokinetics Inc | Health Care | 1.3% |
| Agilysys Inc | Information Technology | 1.3% |
| Fiverr International Ltd | Industrials | 1.3% |
| Natera Inc | Health Care | 1.2% |
| Karuna Therapeutics Inc | Health Care | 1.2% |
| Axonics Inc | Health Care | 1.2% |
| Samsara Inc | Information Technology | 1.2% |
| indie Semiconductor Inc | Information Technology | 1.1% |
| Intra-Cellular Therapies Inc | Health Care | 1.1% |
| Saia Inc | Industrials | 1.1% |
| SiteOne Landscape Supply Inc | Industrials | 1.1% |
| Penumbra Inc | Health Care | 1.0% |
| Comfort Systems USA Inc | Industrials | 1.0% |
| iRhythm Technologies Inc | Health Care | 1.0% |
| Topgolf Callaway Brands Corp | Consumer Discretionary | 1.0% |
| Sprout Social Inc | Information Technology | 1.0% |
| Fox Factory Holding Corp | Consumer Discretionary | 1.0% |
| Allegro MicroSystems Inc | Information Technology | 0.9% |
| Piper Sandler Cos | Financials | 0.9% |
| Arcellx Inc | Health Care | 0.9% |
| Confluent Inc | Information Technology | 0.9% |
| Sarepta Therapeutics Inc | Health Care | 0.9% |
| EMCOR Group Inc | Industrials | 0.9% |
| Inter Parfums Inc | Consumer Staples | 0.9% |
| Monday.com Ltd | Information Technology | 0.9% |
| Smartsheet Inc | Information Technology | 0.9% |
| RBC Bearings Inc | Industrials | 0.8% |
| Texas Roadhouse Inc | Consumer Discretionary | 0.8% |
| PagerDuty Inc | Information Technology | 0.8% |
| Hexcel Corp | Industrials | 0.8% |
| Pliant Therapeutics Inc | Health Care | 0.8% |
| Pacific Biosciences of California Inc | Health Care | 0.8% |
| NEXTracker Inc | Industrials | 0.8% |
| HashiCorp Inc | Information Technology | 0.8% |
| Silk Road Medical Inc | Health Care | 0.8% |
| Applied Industrial Technologies Inc | Industrials | 0.7% |
| Valmont Industries Inc | Industrials | 0.7% |
| Shake Shack Inc | Consumer Discretionary | 0.7% |
| Cirrus Logic Inc | Information Technology | 0.7% |
| Tetra Tech Inc | Industrials | 0.7% |
| FTI Consulting Inc | Industrials | 0.7% |
| nVent Electric PLC | Industrials | 0.7% |
| Silicon Laboratories Inc | Information Technology | 0.7% |
| Madrigal Pharmaceuticals Inc | Health Care | 0.6% |
| AeroVironment Inc | Industrials | 0.6% |
| Integral Ad Science Holding Corp | Communication Services | 0.6% |
| Manhattan Associates Inc | Information Technology | 0.6% |
| Calix Inc | Information Technology | 0.6% |
| Clean Harbors Inc | Industrials | 0.6% |
| CyberArk Software Ltd | Information Technology | 0.5% |
| Descartes Systems Group Inc/The | Information Technology | 0.5% |
| Tenable Holdings Inc | Information Technology | 0.5% |
| Prometheus Biosciences Inc | Health Care | 0.5% |
| Glaukos Corp | Health Care | 0.5% |
| Shoals Technologies Group Inc | Industrials | 0.5% |
| AvidXchange Holdings Inc | Financials | 0.5% |
| Zeta Global Holdings Corp | Information Technology | 0.5% |
| Rocket Pharmaceuticals Inc | Health Care | 0.5% |
| Olink Holding AB | Health Care | 0.5% |
| Gogo Inc | Communication Services | 0.4% |
| NerdWallet Inc | Financials | 0.4% |
| Cerevel Therapeutics Holdings Inc | Health Care | 0.3% |
| Sage Therapeutics Inc | Health Care | 0.3% |
| Gitlab Inc | Information Technology | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 04/28/2023
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.3%
|
|
| Other | 0.0% | |
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.5%
|
|
| Consumer Staples |
0.1%
|
|
| Energy | 0.0% | |
| Financials |
5.5%
|
|
| Health Care |
4.4%
|
|
| Industrials |
 0.8%
|
|
| Information Technology |
10.6%
|
|
| Materials | 0.0% |
Portfolio Details as of 04/28/2023
- Total Net Assets
- $2.60 B
- Number of Holdings
- 91
- Weighted Average Market Cap.
- 5.6 B
- P/B Ratio
- 6.6x
- P/E Ratio
- 28.5x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 06/02/2023
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 02/14/1997 | 02/18/1997 | 03/03/1997 | $0.00000 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2023 | 11/21/2023 | 11/21/2023 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $3.3406 | - | $3.3406 | $27.44 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 06/02/2023
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $19.79 |
| $50,000 to $99,999 | 4.75% | 4.00% | $19.58 |
| $100,000 to $249,999 | 3.95% | 3.25% | $19.42 |
| $250,000 to $499,999 | 2.75% | 2.25% | $19.18 |
| $500,000 to $999,999 | 1.95% | 1.75% | $19.02 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $18.65 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 04/30/2023
| Fund Gross Expense Ratio | Fund Net Expense Ratio | |
|---|---|---|
| 0.94% | 0.94% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||
|
Fund Story
Publish Date:11/03/2015
|
|||||